SIMILAR PATTERNS OF AMINO ACIDS FOR 6HUP_E_DZPE502_0
List of similar pattern of amino acids derived from ASSAM searchHit | Macromolecule/ Organism |
Pfam | Res. | Interface | HETATM | RMSD | Dali Z-score | Seq. Identity (%) | View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1jmo | HEPARIN COFACTOR II (Homo sapiens) |
PF00079(Serpin) | 5 | LEU A 468LEU A 186MET A 143THR A 141LEU A 162 | None | 1.38A | 6hupD-1jmoA:0.06hupE-1jmoA:undetectable | 6hupD-1jmoA:10.876hupE-1jmoA:11.11 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1k3v | CAPSID PROTEIN VP2 (Ungulateprotoparvovirus1) |
PF00740(Parvo_coat) | 5 | PRO A 369THR A 339ASN A 338LEU A 444MET A 441 | None | 1.13A | 6hupD-1k3vA:undetectable6hupE-1k3vA:0.0 | 6hupD-1k3vA:9.796hupE-1k3vA:8.73 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1sy7 | CATALASE 1 (Neurosporacrassa) |
PF00199(Catalase)PF01965(DJ-1_PfpI)PF06628(Catalase-rel) | 5 | LEU A 490MET A 502LEU A 513MET A 216THR A 218 | None | 1.41A | 6hupD-1sy7A:0.06hupE-1sy7A:0.0 | 6hupD-1sy7A:8.966hupE-1sy7A:8.01 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1tyg | THIAZOLEBIOSYNTHESIS PROTEINTHIG (Bacillussubtilis) |
PF05690(ThiG) | 5 | LEU A 230PRO A 231MET A 252LEU A 243THR A 215 | None | 1.29A | 6hupD-1tygA:undetectable6hupE-1tygA:undetectable | 6hupD-1tygA:15.816hupE-1tygA:13.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1w98 | G1/S-SPECIFIC CYCLINE1 (Homo sapiens) |
PF00134(Cyclin_N)PF02984(Cyclin_C) | 5 | PRO B 89LEU B 90MET B 239LEU B 289MET B 298 | None | 1.44A | 6hupD-1w98B:undetectable6hupE-1w98B:0.8 | 6hupD-1w98B:14.086hupE-1w98B:15.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2ec5 | DERMONECROTIC TOXIN (Pasteurellamultocida) |
PF11647(MLD) | 5 | MET A1056LEU A1045ASN A1021LEU A 864MET A 865 | None | 1.42A | 6hupD-2ec5A:0.06hupE-2ec5A:3.8 | 6hupD-2ec5A:7.336hupE-2ec5A:7.42 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2ejw | HOMOSERINEDEHYDROGENASE (Thermusthermophilus) |
PF00742(Homoserine_dh)PF03447(NAD_binding_3) | 5 | LEU A 83PRO A 80LEU A 101THR A 96LEU A 8 | None | 1.48A | 6hupD-2ejwA:0.06hupE-2ejwA:0.0 | 6hupD-2ejwA:14.056hupE-2ejwA:12.05 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2x5f | ASPARTATE_TYROSINE_PHENYLALANINEPYRIDOXAL-5'PHOSPHATE-DEPENDENTAMINOTRANSFERASE (Staphylococcusaureus) |
PF00155(Aminotran_1_2) | 5 | LEU A 251LEU A 106MET A 281THR A 282LEU A 264 | None | 1.27A | 6hupD-2x5fA:0.06hupE-2x5fA:0.0 | 6hupD-2x5fA:11.666hupE-2x5fA:11.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3q80 | 2-C-METHYL-D-ERYTHRITOL 4-PHOSPHATECYTIDYLTRANSFERASE (Mycobacteriumtuberculosis) |
PF01128(IspD) | 5 | LEU A 175LEU A 196THR A 84ASN A 88LEU A 89 | None | 1.40A | 6hupD-3q80A:undetectable6hupE-3q80A:undetectable | 6hupD-3q80A:14.356hupE-3q80A:13.85 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3r18 | SULFITE OXIDASE (Gallus gallus) |
PF00174(Oxidored_molyb)PF03404(Mo-co_dimer) | 5 | LEU A 124PRO A 119LEU A 107THR A 137LEU A 183 | NoneNoneNoneMTE A 501 (-4.2A)None | 1.41A | 6hupD-3r18A:0.06hupE-3r18A:1.8 | 6hupD-3r18A:10.766hupE-3r18A:10.92 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3w04 | DWARF 88 ESTERASE (Oryza sativa) |
PF12697(Abhydrolase_6) | 5 | LEU A 249PRO A 174MET A 151LEU A 177PHE A 176 | NoneNoneNoneNoneMPD A 401 ( 3.7A) | 1.45A | 6hupD-3w04A:undetectable6hupE-3w04A:undetectable | 6hupD-3w04A:15.276hupE-3w04A:14.56 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4c0d | CCR4-NOTTRANSCRIPTIONCOMPLEX SUBUNIT 1 (Homo sapiens) |
PF04054(Not1) | 5 | LEU A2016LEU A1963THR A2022ASN A2021MET A2063 | None | 1.42A | 6hupD-4c0dA:3.16hupE-4c0dA:2.6 | 6hupD-4c0dA:7.986hupE-4c0dA:7.50 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4c0d | CCR4-NOTTRANSCRIPTIONCOMPLEX SUBUNIT 1 (Homo sapiens) |
PF04054(Not1) | 5 | LEU A2016LEU A1963THR A2022ASN A2021PHE A2023 | None | 1.15A | 6hupD-4c0dA:3.16hupE-4c0dA:2.6 | 6hupD-4c0dA:7.986hupE-4c0dA:7.50 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ffl | PYLC (Methanosarcinabarkeri) |
PF02655(ATP-grasp_3) | 5 | LEU A 11MET A 334THR A 333LEU A 289MET A 290 | LYS A 901 (-3.6A)NoneNoneNoneNone | 1.28A | 6hupD-4fflA:undetectable6hupE-4fflA:undetectable | 6hupD-4fflA:13.206hupE-4fflA:16.55 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4uvj | COHESIN SUBUNIT SCC3 (Saccharomycescerevisiae) |
no annotation | 5 | PRO A 841MET A 843LEU A 910LEU A 833PHE A 836 | None | 1.07A | 6hupD-4uvjA:0.06hupE-4uvjA:0.0 | 6hupD-4uvjA:12.956hupE-4uvjA:10.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4wpz | CYTOCHROME P450 (Streptomycesavermitilis) |
PF00067(p450) | 5 | LEU A 285PRO A 284LEU A 22ASN A 322LEU A 344 | HEM A 503 (-4.3A)NoneNoneNoneNone | 1.42A | 6hupD-4wpzA:1.46hupE-4wpzA:1.3 | 6hupD-4wpzA:12.676hupE-4wpzA:10.66 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5fu7 | CCR4-NOTTRANSCRIPTIONCOMPLEX SUBUNIT 1 (Homo sapiens) |
PF04054(Not1) | 5 | LEU A2016LEU A1963THR A2022ASN A2021PHE A2023 | None | 1.18A | 6hupD-5fu7A:1.96hupE-5fu7A:4.1 | 6hupD-5fu7A:11.886hupE-5fu7A:9.19 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5hzg | STRIGOLACTONEESTERASE D14 (Arabidopsisthaliana) |
PF12697(Abhydrolase_6) | 5 | LEU A 199PRO A 124MET A 101LEU A 127PHE A 126 | None | 1.50A | 6hupD-5hzgA:undetectable6hupE-5hzgA:undetectable | 6hupD-5hzgA:15.366hupE-5hzgA:14.55 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5hzg | STRIGOLACTONEESTERASE D14 (Arabidopsisthaliana) |
PF12697(Abhydrolase_6) | 5 | LEU A 199PRO A 124MET A 101LEU A 229PHE A 126 | None | 1.48A | 6hupD-5hzgA:undetectable6hupE-5hzgA:undetectable | 6hupD-5hzgA:15.366hupE-5hzgA:14.55 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6d6u | GAMMA-AMINOBUTYRICACID RECEPTORSUBUNITBETA-2,GAMMA-AMINOBUTYRIC ACID RECEPTORSUBUNIT BETA-2GAMMA-AMINOBUTYRICACID RECEPTORSUBUNITALPHA-1,GAMMA-AMINOBUTYRIC ACID RECEPTORSUBUNIT ALPHA-1 (Homo sapiens;Homo sapiens) |
no annotationno annotation | 6 | LEU B 232PRO B 233LEU B 269THR A 266LEU A 285MET A 286 | None | 1.23A | 6hupD-6d6uB:35.06hupE-6d6uB:33.2 | 6hupD-6d6uB:100.006hupE-6d6uB:28.75 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6d6u | GAMMA-AMINOBUTYRICACID RECEPTORSUBUNITBETA-2,GAMMA-AMINOBUTYRIC ACID RECEPTORSUBUNIT BETA-2GAMMA-AMINOBUTYRICACID RECEPTORSUBUNITALPHA-1,GAMMA-AMINOBUTYRIC ACID RECEPTORSUBUNIT ALPHA-1 (Homo sapiens;Homo sapiens) |
no annotationno annotation | 6 | LEU B 232PRO B 233MET A 261ASN A 265LEU A 285MET A 286 | None | 1.35A | 6hupD-6d6uB:35.06hupE-6d6uB:33.2 | 6hupD-6d6uB:100.006hupE-6d6uB:28.75 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6d6u | GAMMA-AMINOBUTYRICACID RECEPTORSUBUNITBETA-2,GAMMA-AMINOBUTYRIC ACID RECEPTORSUBUNIT BETA-2GAMMA-AMINOBUTYRICACID RECEPTORSUBUNITALPHA-1,GAMMA-AMINOBUTYRIC ACID RECEPTORSUBUNIT ALPHA-1 (Homo sapiens;Homo sapiens) |
no annotationno annotation | 7 | LEU B 232PRO B 233MET A 261THR A 262ASN A 265LEU A 285PHE A 289 | None | 1.00A | 6hupD-6d6uB:35.06hupE-6d6uB:33.2 | 6hupD-6d6uB:100.006hupE-6d6uB:28.75 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6d6u | GAMMA-AMINOBUTYRICACID RECEPTORSUBUNITBETA-2,GAMMA-AMINOBUTYRIC ACID RECEPTORSUBUNIT BETA-2GAMMA-AMINOBUTYRICACID RECEPTORSUBUNITALPHA-1,GAMMA-AMINOBUTYRIC ACID RECEPTORSUBUNIT ALPHA-1 (Homo sapiens;Homo sapiens) |
no annotationno annotation | 5 | LEU B 232PRO B 233MET B 236ASN A 265MET A 286 | None | 1.26A | 6hupD-6d6uB:35.06hupE-6d6uB:33.2 | 6hupD-6d6uB:100.006hupE-6d6uB:28.75 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6d6u | GAMMA-AMINOBUTYRICACID RECEPTORSUBUNITBETA-2,GAMMA-AMINOBUTYRIC ACID RECEPTORSUBUNIT BETA-2GAMMA-AMINOBUTYRICACID RECEPTORSUBUNITALPHA-1,GAMMA-AMINOBUTYRIC ACID RECEPTORSUBUNIT ALPHA-1 (Homo sapiens;Homo sapiens) |
no annotationno annotation | 5 | LEU B 232PRO B 233MET B 236LEU B 269MET A 286 | None | 1.31A | 6hupD-6d6uB:35.06hupE-6d6uB:33.2 | 6hupD-6d6uB:100.006hupE-6d6uB:28.75 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6d6u | GAMMA-AMINOBUTYRICACID RECEPTORSUBUNITBETA-2,GAMMA-AMINOBUTYRIC ACID RECEPTORSUBUNIT BETA-2GAMMA-AMINOBUTYRICACID RECEPTORSUBUNITALPHA-1,GAMMA-AMINOBUTYRIC ACID RECEPTORSUBUNIT ALPHA-1 (Homo sapiens;Homo sapiens) |
no annotationno annotation | 6 | LEU B 232PRO B 233MET B 236THR A 262ASN A 265PHE A 289 | None | 1.13A | 6hupD-6d6uB:35.06hupE-6d6uB:33.2 | 6hupD-6d6uB:100.006hupE-6d6uB:28.75 |